MISSIONPHARMA A/S: Financial statements 2022
CVR: 26902398
Source: annual report 2022, Danish Business Authority
01/04/2021 – 31/03/2022
MISSIONPHARMA A/S (CVR 26902398) has filed annual accounts for 2022. In 2022, the company reported revenue of DKK 693,959,000 and a net result of DKK 57,982,000 compared with DKK 83,607,000 the year before. That is a decrease of 5.1% compared with the year before. The profit margin was 8.4%. Equity in the 2022 report amounted to DKK 312,809,000. The solvency ratio was 73%. The company had 55 employees in the financial year.
- Revenue
- DKK 693,959,000
- Gross Profit
- DKK 122,255,000
- Profit/Loss
- DKK 57,982,000
- Equity
- DKK 312,809,000
- Total Assets
- DKK 428,519,000
- Employees
- 55
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | 694M | 122.3M | 58M | 312.8M | 55 |
| 2021 | 731.5M | 171.9M | 83.6M | 332.4M | 58 |
| 2020 | 777M | 81.5M | 22.2M | 263.2M | 62 |
| 2019 | 117.2M | 17M | 6M | 40.6M | 62 |
| 2017 | 703.5M | 137.1M | 76.2M | 284M | 60 |
Official annual report
Keep an eye on MISSIONPHARMA A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
As of June 29, 2022, Forvis Mazars Statsautoriseret Revisionspartnerselskab has been appointed auditor of MISSIONPHARMA A/S.
As of June 29, 2022, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of MISSIONPHARMA A/S.
About MISSIONPHARMA A/S
MISSIONPHARMA A/S is a Danish company of the type Aktieselskab based in Lynge, founded in 2002. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Jean-Marc Pierre René Leccia and Edouard Marc Marie Favreau. The board consists of Eric Pierre Jean Muris (chair), Kim Erik Ginnerup, Ilona Maureen Fischer and Jean-Marc Pierre René Leccia. The company is owned by CFAO HEALTHCARE SA. The company has 60 employees (2026). In 2026, the company reported revenue of DKK 934,465,000 and a net result of DKK 120,205,000 compared with DKK 73,402,000 the year before. Equity in the 2026 report amounted to DKK 317,751,000.